20
Lonza Braine S.a. Braine-l'alleud Be, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Desmopressin, Liquid phase synthesis process, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2003-208 - Rev 01
This Chemical Type CEP, issued on March 04, 2011, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 712 associated with this CEP further emphasizes